Njira Lugogo, MD
Clinical Professor of Internal Medicine
Medical School
University of Michigan
Medicine
300 North Ingalls St Suite 2c40
Ann Arbor, Michigan 48109
[email protected]
Medicine
300 North Ingalls St Suite 2c40
Ann Arbor, Michigan 48109
Available to mentor
Njira Lugogo, MD
Clinical Professor
Manage Your Profile
Qualifications
-
MSDuke University, Durham, NC, United States
2012 - 2016
-
MDVirginia Commonwealth University, 1201 E Marshall St., 4th Floor P. O. Box 980565, Richmond, VA, 23298-0565, United States
1997 - 2001
-
BSVirginia Polytechnic Institute and State University, Blacksburg, VA, United States
1992 - 1996
Links
twitter https://miasthmaresearch.med.umich.edu/ https://scholar.google.com/scholar?hl=en&as_sdt=0%2C23&q=lugogo%2C+n&btnG= https://www.uofmhealth.org/profile/30571/njira-lucia-lugogo-md
Recent Publications
-
Lugogo NL, Trevor J, Spahn JD, Panettieri RA, Carstens DD, Ambrose CS. Journal of Asthma and Allergy, 2026 May 6; 19: 588118Journal ArticleMortality Among Adults with Subspecialist-Treated Severe Asthma: A Descriptive Analysis from the Observational CHRONICLE Study
DOI:10.2147/jaa.s588118 -
Aegerter H, Brightling CE, Dunican EM, Lambrecht BN, Lugogo NL, Newell JD, Porsbjerg C, Svenningsen S, Clarke D, Lindsley AW, Nordenmark L, Ambrose CS, Castro M. Respiratory Research, 2026 Dec 1; 27 (1):Journal ArticleEffectiveness of biologics for reducing occlusive mucus plugs in patients with severe asthma: a systematic review
DOI:10.1186/s12931-026-03501-z PMID: 41559746 -
Panettieri RA, Mohan A, Lugogo NL, Ledford DK, Carstens DD, Ambrose CS. Respiratory Research, 2026 Dec 1; 27 (1):Journal ArticleOutcomes after biologic initiation among patients with severe asthma and normal lung function in the CHRONICLE study
DOI:10.1186/s12931-025-03439-8 PMID: 41501790 -
Dunican EM, Castro M, Papi A, Backer V, Brightling CE, Bourdin A, Virchow JC, Altincatal A, Gall R, Awad H, Lugogo NL. Am J Respir Crit Care Med, 2026 May 24;Journal ArticleReply to Zhao et al.: Clarifying Structural - Functional Coupling by FeNO Status in VESTIGE.
DOI:10.1093/ajrccm/aamag221 PMID: 42178814 -
Busse WW, Castro M, Lugogo NL, O'Byrne PM, Bacharier LB, Xia C, Ledanois O, Soliman M. Ann Allergy Asthma Immunol, 2026 May 23;Journal ArticleImproved asthma outcomes for dupilumab plus medium-dose inhaled corticosteroids versus placebo plus high-dose inhaled corticosteroids.
DOI:10.1016/j.anai.2026.05.019 PMID: 42178021 -
Patel M, Wise RA, Papi A, Jackson DJ, Lugogo NL, Chen R, Trasieva T, Obasi C, Movitz C, Helman J, Salter P, Springer K, Bondoc M, Shah M, Bowen K, Pandya H, Megally A. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.308Journal ArticleA32-13 Budesonide/Glycopyrrolate/Formoterol Fumarate Effects on Lung Function and Exacerbations by Baseline Asthma Characteristics in Inadequately Controlled Asthma
DOI:10.1093/ajrccm/aamag162.308 -
Patel M, Wise R, Papi A, Jackson DJ, Lugogo NL, Chen R, Trasieva T, Obasi C, Movitz C, Helman J, Salter P, Springer K, Bondoc M, Shah M, Bowen K, Pandya H, Megally A. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.309Journal ArticleA32-14 Budesonide/Glycopyrrolate/Formoterol Fumarate Effects on Lung Function and Exacerbations by Baseline Demographics in Inadequately Controlled Asthma
DOI:10.1093/ajrccm/aamag162.309 -
Patel M, Wise RA, Papi A, Jackson DJ, Lugogo N, Chen R, Trasieva T, Obasi C, Movitz C, Helman J, Salter P, Springer K, Bondoc M, Shah M, Bowen K, Pandya H, Megally A. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.310Journal ArticleA32-15 Budesonide/Glycopyrrolate/Formoterol Fumarate Effects on Patient Reported Outcomes and Symptoms in Inadequately Controlled Asthma
DOI:10.1093/ajrccm/aamag162.310
Featured News & Stories
Health Lab
Using biologic injections for severe asthma after COVID
Biologic injections end up being the best treatment for treating severe asthma after having COVID for one patient.
